Multivitamins are the most commonly consumed dietary supplement in the United States, taken daily by approximately 31% of adults according to the 2023-2024 NHANES data. Yet the U.S. Preventive Services Task Force (USPSTF) — after reviewing 84 studies involving more than 700,000 participants — concluded in 2022 that there is insufficient evidence to recommend multivitamins for the prevention of cardiovascular disease, cancer, or all-cause mortality. The relevant question for most consumers is narrower: does your product contain what the label claims?
Independent testing reveals significant quality problems. ConsumerLab's 2024 multivitamin review — the most comprehensive third-party evaluation conducted annually since 2000 — found that approximately one-third of 54 tested products failed to meet one or more label claims. Common failures: vitamin D content below 60% of labeled amount (the most frequent deficiency), degraded folic acid from poor storage conditions, excessive preformed vitamin A (retinol) exceeding the Tolerable Upper Intake Level of 3,000 mcg RAE, and lead contamination above California's Proposition 65 threshold of 0.5 mcg/day.
Dr. Pieter Cohen, an internist at Harvard Medical School and leading researcher on dietary supplement safety, describes the U.S. supplement market as "the Wild West of consumer health products" — manufacturers are not required to prove efficacy, demonstrate safety, or verify label accuracy before selling. The FDA acts only after problems are reported, not before products reach shelves. This regulatory gap makes third-party testing (USP, NSF International, ConsumerLab, Informed Sport) the only pre-purchase quality assurance available to consumers.
What to look for in a quality multivitamin: Dr. Tod Cooperman, founder of ConsumerLab.com and the most prolific independent supplement tester in the US, recommends methylfolate (5-MTHF) rather than folic acid — approximately 30% of the population carries MTHFR polymorphisms that impair folic acid conversion; vitamin D3 (cholecalciferol) rather than D2 (ergocalciferol), which is 60-87% more effective at raising serum 25(OH)D levels per a 2012 American Journal of Clinical Nutrition meta-analysis; chelated minerals (citrate, glycinate) rather than oxide forms, which have 2-4x higher bioavailability; and no more than 100% of the Daily Value for most nutrients unless correcting a documented deficiency.
What to avoid: proprietary blends that obscure individual ingredient amounts, any product making disease treatment or cure claims (a violation of the DSHEA that signals regulatory non-compliance), artificial dyes (FD&C Red 40, Yellow 5), and any product whose marketing emphasizes transformation over nutrition. Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the VITAL trial (n=25,871), notes that the supplements with the strongest evidence are the ones with the quietest marketing.
The evidence-supported approach: use a basic, third-party tested (USP or NSF verified) multivitamin as nutritional insurance, particularly if your diet is restricted or your caloric intake is below 1,800 kcal/day. Prioritize whole foods as primary nutrient sources and address specific documented deficiencies (vitamin D, iron, B12) with targeted supplementation guided by blood work rather than broad-spectrum megadosing.